IDG Leads in Vaccines Development
04 Jul 2024
US$ 19.00
IDG Capital has led in the over Rmb300 million (US$41.3 million) series C+ funding round of Chengdu Maxvax ......
Related Publications
TA Associates has made a strategic investment in Viridian Financial Group (Viridian) for an undisclosed...
SC Ventures, the investment arm of Standard Chartered Plc, has led a US$120 m series D funding round in Jumbotail...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.